Similar articles for PMID: 25351368

Year	Number of Results
1926	1
1949	1
1953	1
1975	1
1978	1
1982	1
1986	2
1993	1
1995	2
1997	2
1998	3
1999	3
2000	3
2001	3
2002	5
2003	1
2004	2
2005	3
2006	4
2007	8
2008	4
2009	4
2010	4
2011	8
2012	11
2013	8
2014	16
2015	10
2016	13
2017	10
2018	2
2019	5
2020	6
2021	2
2022	5
2023	5
2024	4
2025	0

1

An update on the pharmacotherapy for lower urinary tract dysfunction.

Abraham N, Goldman HB. Abraham N, et al. Expert Opin Pharmacother. 2015 Jan;16(1):79-93. doi: 10.1517/14656566.2015.977253. Epub 2014 Oct 29. Expert Opin Pharmacother. 2015. PMID: 25351368 Review.

2

Urinary incontinence in men: current and developing therapy options.

Burden H, Abrams P. Burden H, et al. Expert Opin Pharmacother. 2016;17(5):715-26. doi: 10.1517/14656566.2016.1145662. Epub 2016 Mar 3. Expert Opin Pharmacother. 2016. PMID: 26800277 Review.

3

Clinical pharmacology of the lower urinary tract. New aspects.

Lose G, Thorup Andersen J. Lose G, et al. Eur Urol. 1986;12(1):1-11. doi: 10.1159/000472568. Eur Urol. 1986. PMID: 2868898 Review.

4

Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.

Yamaguchi O. Yamaguchi O. Int J Urol. 2013 Jan;20(1):28-39. doi: 10.1111/iju.12008. Epub 2012 Nov 28. Int J Urol. 2013. PMID: 23190275 Review.

5

The use of pharmacotherapy for male patients with urgency and stress incontinence.

Andersson KE. Andersson KE. Curr Opin Urol. 2014 Nov;24(6):571-7. doi: 10.1097/MOU.0000000000000106. Curr Opin Urol. 2014. PMID: 25144147 Review.

6

Pharmacological approach to overactive bladder and urge urinary incontinence in women: an overview.

Cipullo LM, Cosimato C, Filippelli A, Conti V, Izzo V, Zullo F, Guida M. Cipullo LM, et al. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:27-34. doi: 10.1016/j.ejogrb.2013.12.024. Epub 2013 Dec 26. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24411952 Review.

7

The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.

Athanasopoulos A, Chapple C, Fowler C, Gratzke C, Kaplan S, Stief C, Tubaro A. Athanasopoulos A, et al. Eur Urol. 2011 Jul;60(1):94-105. doi: 10.1016/j.eururo.2011.03.054. Epub 2011 Apr 9. Eur Urol. 2011. PMID: 21497434 Review.

8

Overactive bladder: pharmacological treatment.

Truzzi JC, Silvinato A, Bernardo WM; Brazilian Society of Urology (SBU). Truzzi JC, et al. Rev Assoc Med Bras (1992). 2017 Mar;63(3):197-202. doi: 10.1590/1806-9282.63.03.197. Rev Assoc Med Bras (1992). 2017. PMID: 28489120 Free article. No abstract available.

9

Therapeutic receptor targets for lower urinary tract dysfunction.

Yoshimura N, Kaiho Y, Miyazato M, Yunoki T, Tai C, Chancellor MB, Tyagi P. Yoshimura N, et al. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):437-48. doi: 10.1007/s00210-007-0209-z. Epub 2007 Nov 21. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18034230 Review.

10

Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.

Cho KJ, Kim JC. Cho KJ, et al. Expert Opin Pharmacother. 2012 Jun;13(8):1143-51. doi: 10.1517/14656566.2012.682149. Expert Opin Pharmacother. 2012. PMID: 22594844 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 25351368

151 results

Results by year